{"id":52629,"date":"2023-01-06T14:02:30","date_gmt":"2023-01-06T13:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/"},"modified":"2023-01-06T14:02:30","modified_gmt":"2023-01-06T13:02:30","slug":"agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/","title":{"rendered":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications"},"content":{"rendered":"
\n

\nWill commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development\n<\/p>\n

<\/a><\/p>\n

SANTA CLARA, Calif, & MARLBOROUGH, Mass.–(BUSINESS WIRE)–Agilent Technologies, Inc.<\/a> (NYSE: A) today announced a partnership with Akoya Biosciences, Inc.<\/a> (Nasdaq: AKYA), The Spatial Biology Company\u00ae, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research market. Integrating Agilent\u2019s Dako Omnis<\/a> (autostaining instrument) and Akoya\u2019s PhenoImager\u00ae HT<\/a> (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays will create a singular end-to-end commercial workflow, including reagents, staining, imaging, and analysis.\n<\/p>\n

\nAgilent and Akoya will partner to develop chromogenic and immunofluorescent multiplex assays that include spatial analysis for biopharma companies developing precision cancer therapeutics. These assay solutions will enable researchers and medical professionals to address patient selection needs of novel therapeutics and rapidly translate their discoveries into clinical testing. Spatial phenotyping using multiplex imaging provides the advantages of single-cell analysis while preserving spatial relationships between the cells. This offers an invaluable tool for uncovering novel insights into cellular organization in the tumor microenvironment and therapeutic response.\n<\/p>\n

\nThis agreement will deliver an end-to-end multiplex solution for biomarker clinical research enabled by digital pathology, providing capabilities across the pharma value chain. Combining Agilent\u2019s companion diagnostic and IHC workflow expertise, the large install base of Dako Omnis instruments, and a strong network of pharma partners; with Akoya\u2019s install base of imagers, spatial analysis expertise, and CLIA lab capabilities will further empower biopharma partners to leverage this integrated workflow solution for their biomarker discovery and validation needs, helping drive better patient stratification. Under a separate Value-Added Reseller agreement, Akoya Biosciences will distribute and resell Dako Omnis as a part of the end-to-end multiplex solution.\n<\/p>\n

\n\u201cWe are delighted to be partnering with Akoya to create industry-leading products and services for multiplex chromogenic and immunofluorescence tissue assays,\u201d said Sam Raha, president of Agilent\u2019s Diagnostic and Genomics Group. \u201cThis partnership enables an ecosystem that assists the development of novel precision cancer therapeutics and offers a streamlined workflow to our joint customers in the clinical research market to meet the needs of future clinical diagnostics,\u201d Raha added.\n<\/p>\n

\n\u201cMultiplex tissue analysis has the potential to transform the field of cancer therapeutics and usher in a new era of precision pathology,\u201d said Brian McKelligon, CEO of Akoya Biosciences. \u201cThis partnership and the combined strength of both organizations will catalyze the development and deployment of multiplex tissue-based biomarkers for the benefit of our biopharma and CRO partners and, ultimately, patients.\u201c\n<\/p>\n

\nAbout Akoya Biosciences<\/strong>\n<\/p>\n

\nAs The Spatial Biology Company\u00ae, Akoya Biosciences\u2019 mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode\u2122 Panels and PhenoCycler\u00ae, PhenoImager\u00ae Fusion, and PhenoImager HT Instruments. To learn more about Akoya, visit www.akoyabio.com<\/a>.\n<\/p>\n

\nAbout Agilent Technologies<\/b>\n<\/p>\n

\nAgilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent\u2019s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com<\/a>. To receive the latest Agilent news, please subscribe to the Agilent Newsroom<\/a>. Follow Agilent on LinkedIn<\/a>, and Facebook<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts
\n
<\/b>Naomi Goumillout
\n
Agilent Technologies
\n
+1.781.266.2819
\n
naomi.goumillout@agilent.com<\/a>
Christine Quern
\n
Akoya Biosciences
\n
+1.617.650.8497
\n
media@akoyabio.com<\/a>\n<\/p>\n

\nInvestor Contact
\n
<\/b>Priyam Shah
\n
Sr. Director, Investor Relations
\n
Akoya Biosciences
\n
investors@akoyabio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company\u00ae, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52629","6":"format-standard","7":"category-industry"},"yoast_head":"\nAgilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company\u00ae, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-06T13:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications\",\"datePublished\":\"2023-01-06T13:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/\"},\"wordCount\":658,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005053\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/\",\"name\":\"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005053\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"datePublished\":\"2023-01-06T13:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005053\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005053\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/","og_locale":"en_US","og_type":"article","og_title":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend","og_description":"Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.–(BUSINESS WIRE)–Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company\u00ae, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-06T13:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications","datePublished":"2023-01-06T13:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/"},"wordCount":658,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/","url":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/","name":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg","datePublished":"2023-01-06T13:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230106005053\/en\/738858\/21\/Logo-Agilent.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/agilent-and-akoya-biosciences-announce-partnership-to-drive-multiplex-tissue-assay-development-for-biopharma-applications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52629"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52629\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}